Hiroshi Tanaka

1958–2025 年に発表

418
論文数
33,309
被引用数
102
h 指数
297
i10 指数

被引用数

Hiroshi Tanaka の年別被引用数1962 年: 被引用 1 件1964 年: 被引用 1 件1965 年: 被引用 1 件1967 年: 被引用 1 件1972 年: 被引用 1 件1975 年: 被引用 1 件1977 年: 被引用 1 件1978 年: 被引用 1 件1981 年: 被引用 2 件1982 年: 被引用 4 件1983 年: 被引用 3 件1984 年: 被引用 3 件1985 年: 被引用 9 件1986 年: 被引用 2 件1987 年: 被引用 11 件1988 年: 被引用 6 件1989 年: 被引用 5 件1990 年: 被引用 15 件1991 年: 被引用 15 件1992 年: 被引用 19 件1993 年: 被引用 31 件1994 年: 被引用 32 件1995 年: 被引用 39 件1996 年: 被引用 35 件1997 年: 被引用 78 件1998 年: 被引用 60 件1999 年: 被引用 49 件2000 年: 被引用 103 件2001 年: 被引用 116 件2002 年: 被引用 120 件2003 年: 被引用 143 件2004 年: 被引用 163 件2005 年: 被引用 193 件2006 年: 被引用 228 件2007 年: 被引用 256 件2008 年: 被引用 217 件2009 年: 被引用 234 件2010 年: 被引用 242 件2011 年: 被引用 276 件2012 年: 被引用 307 件2013 年: 被引用 343 件2014 年: 被引用 291 件2015 年: 被引用 276 件2016 年: 被引用 302 件2017 年: 被引用 287 件2018 年: 被引用 293 件2019 年: 被引用 726 件2020 年: 被引用 955 件2021 年: 被引用 972 件2022 年: 被引用 697 件2023 年: 被引用 519 件2024 年: 被引用 902 件2025 年: 被引用 432 件2026 年: 被引用 17 件1963 年は被引用が無いため表示していません1966 年は被引用が無いため表示していません1968〜1971 年は被引用が無いため表示していません1973〜1974 年は被引用が無いため表示していません1976 年は被引用が無いため表示していません1979〜1980 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,964 件、この内訳の 20.5%中国: 引用元論文 1,758 件、この内訳の 12.2%日本: 引用元論文 1,722 件、この内訳の 11.9%イギリス: 引用元論文 866 件、この内訳の 6%ドイツ: 引用元論文 662 件、この内訳の 4.6%イタリア: 引用元論文 546 件、この内訳の 3.8%フランス: 引用元論文 486 件、この内訳の 3.4%カナダ: 引用元論文 452 件、この内訳の 3.1%オーストラリア: 引用元論文 370 件、この内訳の 2.5%インド: 引用元論文 347 件、この内訳の 2.4%スペイン: 引用元論文 333 件、この内訳の 2.3%オランダ: 引用元論文 315 件、この内訳の 2.2%
0%20.5%その他 25.1%

分野

  • Medicine40.3%
  • Biochemistry, Genetics and Molecular Biology28.7%
  • Agricultural and Biological Sciences7.2%
  • Immunology and Microbiology4.3%
  • Neuroscience4.1%
  • Computer Science4.1%
  • その他11.3%

トピック

  • Lung Cancer Treatments and Mutations1.9%
  • Cancer Immunotherapy and Biomarkers1.4%
  • Plant Molecular Biology Research1.4%
  • Lung Cancer Research Studies1.2%
  • Genetic Neurodegenerative Diseases1.1%
  • Mitochondrial Function and Pathology1.1%
  • その他91.9%

共著者

全論文

検索で開く
  1. AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2019 被引用: 363

  2. Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Walburga Engel-Riedel, Stefan Hammerschmidt, Wolfgang Schütte, Konstantinos Syrigos, Jcm Ho, Kwok‐Hung Au, Silvia Novello, Andrea Ardizzoni, Giulia Pasello, Vanessa Gregorc, Alessandro Del Conte, Domenico Galetta, Toshiaki Takahashi, Kazuhiko Nakagawa, Makoto Nishio, Kiyotaka Yoh, Takashi Seto, Fumio Imamura, Toru Kumagai, Katsuyuki Hotta, Yasushi Goto, Yukio Hosomi, Hiroshi Sakai, Yuichi Takiguchi, Young Hak Kim, Takayasu Kurata, Hiroyuki Yamaguchi, Haruko Daga, Isamu Okamoto, Miyako Satouchi, Satoshi Ikeda, Kazuo Kasahara, Shinji Atagi, Koichi Azuma, Toru Kumagai, Keisuke Aoe, Toru Kumagai, Keisuke Aoe, Yoshitsugu Horio, Nobuyuki Yamamoto, Hiroshi Tanaka, Satoshi Watanabe, Naoyuki Nogami, Tomohiro Ozaki, Ryo Koyama, Tomonori Hirashima, Hiroyasu Kaneda, Keisuke Tomii, Yuka Fujita, Masahiro Seike, Naoki Nishimura, Terufumi Kato, Masao Ichiki, Hideo Saka, Katsuya Hirano, Yasuharu Nakahara, Shunichi Sugawara, Keunchil Park, Sang‐We Kim, Young Joo Min, Hyun Woo Lee, Jin‐Hyoung Kang, Ho Jung An, Ki Hyeong Lee, Jin-Soo Kim, Gyeong‐Won Lee, Sung Yong Lee, Aurelia Alexandru, Anghel Adrian Udrea, Óscar Juan ほか 31 名 - The Lancet Oncology 2019 被引用: 613

  3. Injection of Cultured Cells with a ROCK Inhibitor for Bullous Keratopathy

    著者: , , , , , , , , , , , , , , , - New England Journal of Medicine 2018 被引用: 555

  4. Early infection of scutellum tissue with Agrobacterium allows high‐speed transformation of rice

    著者: , , , , , , - The Plant Journal 2006 被引用: 804

  5. Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Daniel Brungs, Bo Gao, Adnan Nagria, Christos S. Karapetis, Sagun Parakh, Cheol Park, Gaëtan Catala, Frédéric Forget, Sebahat Ocak, Naveen S. Basappa, Geoffrey Liu, Ines B. Menjak, Benjamin Shieh, Shun Lü, Feng Luo, Hongmei Sun, Jialei Wang, Yu Yao, Milada Zemanová, Jaafar Bennouna, Nicolas Girard, Laurent Greillier, Corinne Lamour, H. Léna, Céline Mascaux, Julien Mazières, Denis Moro‐Sibilot, M. Pérol, Elvire Pons‐Tostivint, Virginie Westeel, Akin Atmaca, Christine Greil, Niels Reinmuth, Christian Schumann, Thomas Wehler, Juergen Wolf, James Ho, Csaba Böcskei, Federico Cappuzzo, Filippo de Marinis, Claudia Proto, Manlio Mencoboni, Silvia Novello, Stefania Salvagni, Héctor Soto Parrà, Haruko Daga, Yasushi Goto, Hidetoshi Hayashi, Satoru Kitazono, Kiyotaka Yoh, Ryo Ko, Masashi Kondo, Toshiyuki Kozuki, Takayasu Kurata, Hideaki Mizutani, Kadoaki Ohashi, Satoshi Oizumi, Isamu Okamoto, Satoshi Sakaguchi, H Ozasa, Shunichi Sugawara, Yuichi Tambo, Motohiro Tamiya, Hiroshi Tanaka, Isamu Okamoto, Froylán López-López, Francisco Javier Ramírez Godinez, Jerónimo Rafael Rodríguez Cid, Robin Cornelissen, Steven Gans ほか 61 名 - Journal of Clinical Oncology 2024 被引用: 182

  6. Nivolumab with carboplatin, paclitaxel, and bevacizumab for first-line treatment of advanced nonsquamous non-small-cell lung cancer

    著者: , , , , , , , , , , , , , , , , , , - Annals of Oncology 2021 被引用: 199

  7. Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cells

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dan Goldowitz, Reto Guler, Thomas J Ha, Mitsuko Hara, Meenhard Herlyn, Tomokatsu Ikawa, Chieko Kai, Hiroshi Kawamoto, Levon M. Khachigian, S. Peter Klinken, Soichi Kojima, Haruhiko Koseki, Sarah Klein, Niklas Mejhert, Ken Miyaguchi, Yosuke Mizuno, Mitsuru Morimoto, Kelly J Morris, Christine L. Mummery, Yutaka Nakachi, Soichi Ogishima, Mariko Okada, Yasushi Okazaki, Valerio Orlando, Dmitry A. Ovchinnikov, Robert Passier, Margaret Patrikakis, Ana Pombo, Xian‐Yang Qin, Sugata Roy, Hiroki Sato, Suzana Savvi, Alka Saxena, Anita Schwegmann, Daisuke Sugiyama, Rolf Swoboda, Hiroshi Tanaka, Andru Tomoiu, Louise N Winteringham, Ernst J. Wolvetang, Chiyo Yanagi-Mizuochi, Misako Yoneda, Susan E. Zabierowski, Peter Zhang, Imad Abugessaisa, Nicolas Bertin, Alexander D. Diehl, Shiro Fukuda, Masaaki Furuno, Jayson Harshbarger, Akira Hasegawa, Fumi Hori, Sachi Ishikawa-Kato, Yuri Ishizu, Masayoshi Itoh, Tsugumi Kawashima, Miki Kojima, Naoto Kondo, Marina Lizio, Terrence F. Meehan, Chris Mungall, Mitsuyoshi Murata, Hiromi Nishiyori-Sueki, Serkan Sahin, Sayaka Nagao-Sato, Jessica Severin, Michiel de Hoon, Jun Kawai, Takeya Kasukawa, Timo Lassmann ほか 9 名 - Science 2015 被引用: 617

  8. Erect leaves caused by brassinosteroid deficiency increase biomass production and grain yield in rice

    著者: , , , , , , , , , , , , - Nature Biotechnology 2005 被引用: 746

  9. The Tohoku Medical Megabank Project: Design and Mission

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jun Yasuda, Kazuhiko Igarashi, Ritsuko Shimizu, Masao Nagasaki, S. Koshiba, Kengo Kinoshita, Soichi Ogishima, Takako Takai‐Igarashi, Teiji Tominaga, Osamu Tanabe, Noriaki Ohuchi, Toru Shimosegawa, Shigeo Kure, Hiroshi Tanaka, Sadayoshi Ito, Jiro Hitomi, Kozo Tanno, Motoyuki Nakamura, Kuniaki Ogasawara, Seiichiro Kobayashi, Kiyomi Sakata, Mamoru Satoh, Atsushi Shimizu, Makoto Sasaki, Ryujin Endo, Kenji Sobue, Masayuki Yamamoto - Journal of Epidemiology 2016 被引用: 380

  10. Loss of Keap1 Function Activates Nrf2 and Provides Advantages for Lung Cancer Cell Growth

    著者: , , , , , , , , , , , , - Cancer Research 2008 被引用: 628

  11. Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , San‐e Ishikawa, Masafumi Kakei, Kazuyuki Namai, Naotake Hashimoto, Yoshifumi Suzuki, Shunichiro Onishi, Koutaro Yokote, Masafumi Matsuda, Masahiro Masuzawa, Yoichi Hayashi, Satoshi Saitô, Norikazu Ogihara, Hisamitsu Ishihara, Naoko Tajima, Kazunori Utsunomiya, Akira Shimada, Hiroshi Itoh, Ryuzo Kawamori, Hirotaka Watada, Michio Hayashi, Yasumichi Mori, Teruo Shiba, Akihiro Isogawa, Hiroshi Sakura, Masato Odawara, Kazuyuki Tobe, Kazuhisa Tsukamoto, Toshimasa Yamauchi, Tamio Teramoto, Yukio Hirata, Isao UCHIMURA, Yoshihiro Ogawa, Gen Yoshino, Takahisa Hirose, Hiroshi Kajio, Yoshihito Atsumi, Akira Shimada, Yoichi Oikawa, Atsushi Araki, Akio Ueki, Atsushi Ohno, Masafumi Kitaoka, Yoshikuni Fujita, Tatsumi Moriya, Taiki Tojo, Masayoshi Shichiri, Daisuke Suzuki, Masao Toyoda, Kumiko Hamano, Rieko Komi, Yasuo Terauchi, Nobuaki Kuzuya, Masayo Yamada, Toshinari Takamura, Mitsuo Imura, Hiroshi Tanaka, Masayuki Hayashi, Yasuhisa Kato, Mitsuyasu Itoh, Atsushi Suzuki, Mikihiro Nakayama, Takahisa Sano, Eitaro Nakashima, Yasuhiro Sumida, Yutaka Yano, Tsuyoshi Tanaka, Kazuya Murata, Atsunori Kashiwagi, Hiroshi Maegawa, Shigeo Kono ほか 57 名 - The Lancet Diabetes & Endocrinology 2017 被引用: 309

  12. Five-Year Follow-up of First 11 Patients Undergoing Injection of Cultured Corneal Endothelial Cells for Corneal Endothelial Failure

    著者: , , , , , , , , , , , - Ophthalmology 2020 被引用: 169

  13. Cohort Profile: Tohoku Medical Megabank Project Birth and Three-Generation Cohort Study (TMM BirThree Cohort Study): rationale, progress and perspective

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Koichi Chida, Eiichi Kodama, Hideyasu Kiyomoto, Tadashi Ishii, Akito Tsuboi, Hiroaki Tomita, Yasuyuki Taki, Hiroshi Kawame, Kichiya Suzuki, Naoto Ishii, Soichi Ogishima, Satoshi Mizuno, Takako Takai‐Igarashi, Naoko Minegishi, Jun Yasuda, Kazuhiko Igarashi, Ritsuko Shimizu, Masao Nagasaki, Osamu Tanabe, S. Koshiba, Hiroaki Hashizume, Hozumi Motohashi, Teiji Tominaga, Sadayoshi Ito, Kozo Tanno, Kiyomi Sakata, Atsushi Shimizu, Jiro Hitomi, Makoto Sasaki, Kengo Kinoshita, Hiroshi Tanaka, Tadao Kobayashi, Shigeo Kure, Nobuo Yaegashi, Masayuki Yamamoto - International Journal of Epidemiology 2019 被引用: 197

  14. Artificial intelligence-based computational framework for drug-target prioritization and inference of novel repositionable drugs for Alzheimer’s disease

    著者: , , , , , , , , , - Alzheimer s Research & Therapy 2021 被引用: 69

  15. Phase II study of atezolizumab with bevacizumab for non-squamous non-small cell lung cancer with high PD-L1 expression (@Be Study)

    著者: , , , , , , , , , , , , , , , , , , , - Journal for ImmunoTherapy of Cancer 2022 被引用: 49

  16. Bile Salt Hydrolase of Bifidobacterium longum —Biochemical and Genetic Characterization

    著者: , , , - Applied and Environmental Microbiology 2000 被引用: 281

  17. 2O IMpower010: Biomarkers of disease-free survival (DFS) in a phase III study of atezolizumab (atezo) vs best supportive care (BSC) after adjuvant chemotherapy in stage IB-IIIA NSCLC

    著者: , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2021 被引用: 66

  18. Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell

    著者: , , , , , , , , , , , , , , , , , , , - Nature Communications 2012 被引用: 383

  19. Neopentyl Glycol as a Scaffold to Provide Radiohalogenated Theranostic Pairs of High In Vivo Stability

    著者: , , , , , , , , , , , , , , , - Journal of Medicinal Chemistry 2021 被引用: 52

  20. Study Profile of the Tohoku Medical Megabank Community-Based Cohort Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Takako Takai‐Igarashi, Soichi Ogishima, Mamoru Satoh, Hideki Ohmomo, Akito Tsuboi, Shinichi Egawa, Tadashi Ishii, Kiyoshi Ito, Sadayoshi Ito, Yasuyuki Taki, Naoko Minegishi, Naoto Ishii, Masao Nagasaki, Kazuhiko Igarashi, S. Koshiba, Ritsuko Shimizu, Gen Tamiya, Keiko Nakayama, Hozumi Motohashi, Jun Yasuda, Atsushi Shimizu, Tsuyoshi Hachiya, Yuh Shiwa, Teiji Tominaga, Hiroshi Tanaka, Kotaro Oyama, Ryoichi Tanaka, Hiroshi Kawame, Akimune Fukushima, Yasushi Ishigaki, Tomoharu Tokutomi, Noriko Osumi, Tadao Kobayashi, Fuji Nagami, Hiroaki Hashizume, Tomohiko Arai, Yoshio Kawaguchi, Shinichi Higuchi, Masaki Sakaida, Ryujin Endo, Satoshi Nishizuka, Ichiro Tsuji, Jiro Hitomi, Motoyuki Nakamura, Kuniaki Ogasawara, Nobuo Yaegashi, Kengo Kinoshita, Shigeo Kure, Akio Sakai, Seiichiro Kobayashi, Kenji Sobue, Makoto Sasaki, Masayuki Yamamoto - Journal of Epidemiology 2020 被引用: 166

  21. Altered Gut Flora and Environment in Patients with Severe SIRS

    著者: , , , , , , , , , , , , - The Journal of Trauma: Injury, The Journal of Trauma: Injury, Infection, and Critical Care 2006 被引用: 260

  22. Redox-dependent internalization of the purinergic P2Y 6 receptor limits colitis progression

    著者: , , , , , , , , , , , , , , - Science Signaling 2022 被引用: 30

  23. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage

    著者: , , , , , , , - Nature 2000 被引用: 908

  24. Clinical Significance of Osteoprotegerin Expression in Human Colorectal Cancer

    著者: , , , , , , , , - Clinical Cancer Research 2011 被引用: 216